Human MYRF/11orf9/C11orf9 ORF/cDNA clone-Lentivirus particle (NM_013279.4)

Cat. No.: vGMLV002051

Pre-made Human MYRF/11orf9/C11orf9 Lentiviral expression plasmid for MYRF lentivirus packaging, MYRF lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to MYRF/11orf9 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLV002051 Human MYRF Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLV002051
Gene Name MYRF
Accession Number NM_013279.4
Gene ID 745
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 3336 bp
Gene Alias 11orf9,C11orf9,CUGS,MMERV,MRF,Ndt80,pqn-47
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 1xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGCACTGGCTTCCAGCAGGCCACGACATCAACGGTGCCCTGGAGCCCTCCAACATAGACACCAGCATCCTGGAGGAGTACATCAGCAAGGAGGATGCCTCCGACCTCTGCTTCCCTGACATCTCTGCTCCAGCCAGCTCGGCCTCCTACTCCCACGGGCAGCCTGCGATGCCTGGCTCCAGCGGGGTCCACCACCTGAGCCCCCCTGGGGGTGGACCCTCCCCGGGGCGCCATGGTCCCCTCCCACCCCCGGGCTACGGCACCCCGCTGAACTGCAACAACAACAACGGCATGGGCGCTGCCCCCAAGCCCTTCCCGGGGGGCACCGGGCCCCCCATCAAGGCTGAGCCCAAGGCTCCCTATGCCCCAGGCACACTGCCGGACTCTCCCCCAGACTCGGGCTCCGAGGCCTACTCCCCCCAGCAGGTGAATGAGCCCCACCTCCTGCGCACGATAACCCCTGAGACACTGTGCCACGTGGGAGTGCCCTCCCGCCTGGAGCATCCGCCCCCACCTCCAGCCCACTTGCCAGGCCCCCCGCCACCCCCACCACCCCCACCTCACTACCCTGTCCTGCAGCGGGATCTGTACATGAAGGCCGAGCCCCCGATCCCCCACTACGCTGCCATGGGGCAGGGGCTGGTGCCCACTGATCTTCACCACACCCAGCAGTCCCAGATGCTGCACCAGCTCCTGCAGCAGCACGGAGCTGAGCTCCCTACACACCCCTCCAAGAAGAGGAAGCACTCTGAATCCCCCCCCAGCACCCTCAATGCCCAGATGCTGAATGGAATGATCAAACAGGAGCCTGGGACCGTGACAGCCCTGCCTCTGCACCCCACTCGAGCCCCATCGCCACCCTGGCCTCCCCAGGGTCCGCTCTCCCCGGGCCCTGGTTCCTTGCCTCTCAGCATTGCCCGTGTCCAGACACCGCCTTGGCACCCGCCAGGTGCCCCCTCCCCAGGCCTCCTGCAGGACAGTGACAGCCTCAGTGGCTCCTACCTGGACCCCAACTACCAGTCCATCAAGTGGCAGCCTCATCAGCAGAACAAGTGGGCGACCCTGTACGATGCTAACTACAAGGAGCTGCCCATGCTCACCTACCGCGTGGATGCGGACAAGGGCTTCAACTTTTCGGTGGGCGACGACGCCTTTGTGTGCCAGAAGAAGAACCACTTCCAGGTGACAGTGTACATCGGCATGCTGGGCGAGCCCAAGTACGTCAAGACGCCCGAGGGCCTCAAGCCCCTCGACTGCTTCTATCTGAAGCTGCACGGAGTGAAGCTGGAGGCCCTGAACCAGTCCATTAACATCGAGCAGTCCCAGTCAGACCGGAGCAAGCGGCCCTTCAACCCGGTCACGGTCAATCTGCCCCCTGAGCAGGTCACGAAGGTGACTGTGGGGCGGCTGCACTTCAGCGAGACCACCGCTAACAACATGCGTAAGAAGGGCAAGCCCAACCCGGACCAGAGGTACTTCATGCTGGTGGTGGCCCTCCAGGCTCATGCACAGAACCAGAACTACACGCTGGCCGCCCAGATCTCAGAGCGCATCATTGTGCGGGCCTCCAACCCAGGCCAGTTCGAGAGCGACAGCGATGTGTTGTGGCAGCGGGCACAGGTGCCCGACACCGTCTTCCACCACGGCCGCGTGGGCATCAACACAGACCGGCCGGATGAGGCGCTGGTTGTGCACGGGAATGTCAAGGTCATGGGCTCGCTTATGCACCCCTCCGACCTGCGCGCCAAGGAACACGTGCAGGAGGTGGACACCACCGAGCAATTGAAGAGGATCTCGCGCATGCGGCTGGTGCACTACAGATACAAGCCCGAGTTCGCCGCCAGCGCGGGCATCGAGGCCACCGCGCCAGAGACAGGTGTCATCGCTCAGGAGGTGAAGGAGATCTTGCCTGAGGCTGTGAAAGACACCGGAGACATGGTCTTTGCCAATGGGAAAACCATAGAGAACTTCCTGGTGGTGAACAAGGAGCGCATCTTCATGGAGAACGTAGGGGCCGTGAAGGAGCTGTGCAAGCTGACAGACAACCTGGAGACGCGCATTGATGAGCTGGAGCGCTGGAGCCACAAGCTGGCCAAGCTGCGGCGGCTCGACAGCCTCAAGTCCACCGGCAGCTCGGGCGCCTTCAGCCATGCAGGGAGCCAGTTCAGTCGGGCGGGCAGCGTCCCCCACAAGAAGAGGCCCCCCAAGGTGGCCAGCAAGTCATCGTCCGTGGTTCCGGACCAGGCCTGCATCAGCCAGCGCTTCCTGCAGGGAACCATCATTGCCCTGGTGGTGGTCATGGCCTTCAGCGTGGTGTCCATGTCCACACTGTACGTGCTGAGCCTGCGCACAGAGGAGGACCTGGTAGACACTGATGGCAGGTCCAGCCAGAGCTTTGGGACCACGCAGCTCCGACAGTCCCCCTTGACCACGGGGCTACCAGGCATACAGCCCTCTTTGCTGCTGGTGACCACCAGCCTCACCAGCTCGGCCCCAGGTTCTGCTGTCCGCACCTTGGACATGTGTTCCAGCCACCCCTGCCCTGTCATCTGCTGTTCCTCACCCACTACCAACCCTACCACTGGTCCTAGTCTTGGCCCCAGCTTTAACCCTGGCCATGTTCTCAGCCCAAGTCCCAGCCCCAGCACCAACCGCTCAGGCCCCAGCCAGATGGCCCTTCTGCCAGTCACCAACATCAGAGCCAAGTCCTGGGGTCTTTCAGTCAATGGCATTGGCCACTCCAAGCATCACAAGAGTCTGGAGCCTCTGGCCAGCCCTGCAGTCCCCTTCCCTGGGGGGCAGGGCAAAGCCAAGAACAGTCCCAGCCTTGGTTTCCATGGCCGGGCCCGCCGAGGGGCCCTCCAGTCCAGCGTGGGCCCTGCTGAGCCCACCTGGGCCCAGGGCCAGTCAGAGCCAGTGCCCTCCCTGACCTCCATCCAGGTGCTGGAGAATTCGATGTCCATCACCTCCCAGTACTGTGCTCCAGGGGATGCCTGCAGGCCTGGGAACTTCACCTACCACATCCCTGTCAGTAGTGGCACCCCACTGCACCTCAGCCTGACTCTGCAGATGAACTCCTCCTCCCCCGTGTCTGTGGTGCTGTGCAGCCTGAGGTCAAAGGAGGAACCATGTGAGGAGGGGAGCCTTCCACAGAGTCTCCACACCCACCAGGACACCCAGGGCACCTCTCACCGGTGGCCAATAACCATCCTGTCCTTCCGTGAATTCACCTACCACTTCCGGGTGGCACTGCTGGGTCAGGCCAACTGCAGTTCAGAGGCTCTCGCCCAGCCAGCCACAGACTACCACTTCCACTTCTACCGCCTGTGTGACTGA
ORF Protein Sequence MHWLPAGHDINGALEPSNIDTSILEEYISKEDASDLCFPDISAPASSASYSHGQPAMPGSSGVHHLSPPGGGPSPGRHGPLPPPGYGTPLNCNNNNGMGAAPKPFPGGTGPPIKAEPKAPYAPGTLPDSPPDSGSEAYSPQQVNEPHLLRTITPETLCHVGVPSRLEHPPPPPAHLPGPPPPPPPPPHYPVLQRDLYMKAEPPIPHYAAMGQGLVPTDLHHTQQSQMLHQLLQQHGAELPTHPSKKRKHSESPPSTLNAQMLNGMIKQEPGTVTALPLHPTRAPSPPWPPQGPLSPGPGSLPLSIARVQTPPWHPPGAPSPGLLQDSDSLSGSYLDPNYQSIKWQPHQQNKWATLYDANYKELPMLTYRVDADKGFNFSVGDDAFVCQKKNHFQVTVYIGMLGEPKYVKTPEGLKPLDCFYLKLHGVKLEALNQSINIEQSQSDRSKRPFNPVTVNLPPEQVTKVTVGRLHFSETTANNMRKKGKPNPDQRYFMLVVALQAHAQNQNYTLAAQISERIIVRASNPGQFESDSDVLWQRAQVPDTVFHHGRVGINTDRPDEALVVHGNVKVMGSLMHPSDLRAKEHVQEVDTTEQLKRISRMRLVHYRYKPEFAASAGIEATAPETGVIAQEVKEILPEAVKDTGDMVFANGKTIENFLVVNKERIFMENVGAVKELCKLTDNLETRIDELERWSHKLAKLRRLDSLKSTGSSGAFSHAGSQFSRAGSVPHKKRPPKVASKSSSVVPDQACISQRFLQGTIIALVVVMAFSVVSMSTLYVLSLRTEEDLVDTDGRSSQSFGTTQLRQSPLTTGLPGIQPSLLLVTTSLTSSAPGSAVRTLDMCSSHPCPVICCSSPTTNPTTGPSLGPSFNPGHVLSPSPSPSTNRSGPSQMALLPVTNIRAKSWGLSVNGIGHSKHHKSLEPLASPAVPFPGGQGKAKNSPSLGFHGRARRGALQSSVGPAEPTWAQGQSEPVPSLTSIQVLENSMSITSQYCAPGDACRPGNFTYHIPVSSGTPLHLSLTLQMNSSSPVSVVLCSLRSKEEPCEEGSLPQSLHTHQDTQGTSHRWPITILSFREFTYHFRVALLGQANCSSEALAQPATDYHFHFYRLCD

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP1229-Ab Anti-MYRF monoclonal antibody
    Target Antigen GM-Tg-g-IP1229-Ag MYRF protein
    ORF Viral Vector pGMLV002051 Human MYRF Lentivirus plasmid
    ORF Viral Vector vGMLV002051 Human MYRF Lentivirus particle


    Target information

    Target ID GM-IP1229
    Target Name MYRF
    Gene Group Identifier
    （Target Gene ID in Homo species)         		745
    Gene ID 100059805 (Equus caballus), 101083206 (Felis catus), 225908 (Mus musculus), 293736 (Rattus norvegicus)
    483794 (Canis lupus familiaris), 509704 (Bos taurus), 719083 (Macaca mulatta), 745 (Homo sapiens)
    Gene Symbols & Synonyms MYRF,Myrf,CD1H11orf9,Mrf,Gm98,Gm1804,6030439E18,RGD1306622,C18H11orf9,C29H11orf9,C11orf9,C14H11orf9,MRF,CUGS,MMERV,Ndt80,11orf9,pqn-47
    Target Alternative Names 11orf9,6030439E18,C11orf9,C14H11orf9,C18H11orf9,C29H11orf9,CD1H11orf9,CUGS,Gm1804,Gm98,MMERV,MRF,MYRF,Mrf,Myelin gene regulatory factor,Myelin regulatory factor,Myrf,Ndt80,RGD1306622,pqn-47
    Uniprot Accession Q3UR85,Q9Y2G1
    Additional SwissProt Accessions: Q3UR85,Q9Y2G1
    Uniprot Entry Name
    Protein Sub-location Introcelluar Protein
    Category
    Disease
    Disease from KEGG
    Gene Ensembl ENSECAG00000021799, ENSMUSG00000036098, ENSCAFG00845011527, ENSBTAG00000006990, ENSMMUG00000006655, ENSG00000124920
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.